Profile data is unavailable for this security.
About the company
Guardion Health Sciences, Inc. is a clinical nutrition company. The Company offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The Company, through Activ Nutritional, LLC (Activ), owns the Viactiv line of supplements for bone health and other applications. The Viactiv line of supplements contains several flavored nutritional supplement products, but the milk chocolate and caramel flavored calcium chews constitute the main product category. It also sells Lumega-Z, its medical food product that has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. The Company's GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress.
- Revenue in USD (TTM)12.06m
- Net income in USD-5.12m
- Incorporated2015
- Employees9.00
- LocationGuardion Health Sciences Inc2925 Richmond Avenue, Suite 1200HOUSTON 77098United StatesUSA
- Phone+0 (1800) 873-5141
- Fax+1 (858) 630-5543
- Websitehttps://www.guardionhealth.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Psyence Biomedical Ltd | 0.00 | 1.52m | 11.06m | -- | -- | -- | 7.30 | -- | -0.0442 | -0.0442 | 0.00 | -0.3979 | 0.00 | -- | -- | -- | 1.13 | -- | 1.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2.63 | -- | -- | -- |
GlucoTrack Inc | 0.00 | -8.74m | 11.07m | 6.00 | -- | 28.75 | -- | -- | -1.87 | -1.87 | 0.00 | 0.0703 | 0.00 | -- | -- | 0.00 | -520.58 | -94.01 | -2,110.63 | -142.35 | -- | -- | -- | -10,447.96 | -- | -- | 0.3415 | -- | -- | -- | -60.02 | -- | -- | -- |
Enzolytics Inc | 0.00 | -119.19k | 11.16m | 2.00 | -- | -- | -- | -- | -0.106 | -0.106 | 0.00 | -1.04 | 0.00 | -- | -- | -- | -369.52 | -- | -- | -- | -- | -- | -- | -- | -- | -4.30 | -- | -- | -100.00 | -- | -9.35 | -- | -- | -- |
ABVC Biopharma Inc | 25.37k | -12.62m | 11.16m | 16.00 | -- | 1.41 | -- | 439.93 | -2.37 | -2.37 | 0.0043 | 0.7284 | 0.002 | -- | 0.0673 | 1,585.63 | -103.15 | -103.38 | -189.31 | -231.54 | -854.20 | 76.25 | -51,218.29 | -2,019.89 | -- | -3.19 | 0.1853 | -- | -84.28 | 85.39 | 35.97 | -- | -- | -- |
Medical Marijuana Inc | -100.00bn | -100.00bn | 11.37m | -- | -- | 0.1052 | -- | -- | -- | -- | -- | 0.019 | -- | -- | -- | -- | -- | -22.66 | -- | -23.11 | -- | 70.58 | -- | -145.52 | 1.79 | -- | 0.0479 | -- | 26.30 | 39.07 | 141.59 | -- | -0.016 | -- |
Avalo Therapeutics Inc | 1.45m | -142.88m | 11.53m | 19.00 | -- | -- | -- | 7.95 | -318.69 | -318.69 | 3.02 | -97.75 | 0.0181 | -- | 3.25 | 76,315.79 | -178.64 | -99.64 | -- | -154.42 | 54.90 | 84.69 | -9,853.73 | -613.58 | -- | -0.2415 | -- | -- | -89.34 | -22.83 | 24.28 | -- | -22.48 | -- |
Bon Natural Life Ltd | 29.52m | 4.60m | 11.63m | 96.00 | 0.5871 | 0.0969 | 2.11 | 0.3941 | 4.99 | 4.99 | 32.10 | 30.23 | 0.7045 | 15.27 | 5.19 | 307,524.60 | 10.86 | 14.04 | 13.69 | 20.68 | 29.94 | 30.00 | 15.42 | 17.62 | 2.41 | 30.54 | 0.0955 | 0.00 | -1.29 | 22.32 | -26.32 | 83.09 | -6.70 | -- |
Guardion Health Sciences Inc | 12.06m | -5.12m | 11.69m | 9.00 | -- | 3.42 | -- | 0.9693 | -4.00 | -4.00 | 9.49 | 2.66 | 0.9718 | 2.63 | 5.96 | 1,340,280.00 | -41.26 | -77.90 | -47.92 | -86.55 | 43.43 | 42.45 | -42.46 | -176.93 | 6.49 | -4.24 | 0.00 | -- | 10.85 | 67.03 | 101.00 | -- | -58.56 | -- |
Moleculin Biotech Inc | 0.00 | -26.82m | 11.90m | 18.00 | -- | 0.5515 | -- | -- | -12.94 | -12.94 | 0.00 | 9.34 | 0.00 | -- | -- | 0.00 | -65.50 | -46.84 | -75.07 | -51.49 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -2.56 | -- | -21.54 | -- |
Chemomab Therapeutics Ltd - ADR | 0.00 | -19.34m | 11.93m | 20.00 | -- | -- | -- | -- | -26.80 | -26.80 | 0.00 | -- | 0.00 | -- | -- | 0.00 | -72.94 | -- | -92.90 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 12.39 | -- | -- | -- |
Pioneer Green Farms Inc | 9.29k | -403.37k | 11.94m | 6.00 | -- | -- | -- | 1,285.15 | -0.0172 | -0.0172 | 0.0004 | -0.026 | 0.0154 | 0.3035 | -- | 1,548.33 | -66.94 | -- | -- | -- | 41.44 | -- | -4,341.98 | -- | 0.0106 | -30.89 | -- | -- | -- | -- | 35.41 | -- | -- | -- |
Calidi Biotherapeutics Inc | 0.00 | -29.98m | 12.16m | 41.00 | -- | -- | -- | -- | -0.6765 | -0.6765 | 0.00 | -0.4079 | 0.00 | -- | -- | 0.00 | -382.78 | -- | -- | -- | -- | -- | -- | -- | -- | -27.45 | -- | -- | -100.00 | -- | -14.90 | -- | -- | -- |
Marizyme Inc | 645.81k | -65.35m | 12.26m | 11.00 | -- | -- | -- | 18.98 | -1.43 | -1.43 | 0.0142 | -0.0354 | 0.0213 | 1.56 | 8.72 | 58,710.00 | -215.30 | -59.02 | -351.53 | -64.47 | 70.87 | 70.38 | -10,118.60 | -9,435.92 | 0.0458 | -0.6565 | 1.36 | -- | 176.59 | 99.98 | -71.22 | -- | -- | -- |
Plus Therapeutics Inc (USA) | 6.08m | -11.77m | 12.32m | 20.00 | -- | -- | -- | 2.03 | -3.19 | -3.19 | 1.67 | -1.13 | 0.5724 | -- | -- | 304,200.00 | -110.75 | -59.18 | -- | -133.04 | -- | -- | -193.49 | -470.45 | -- | -- | -- | -- | 2,093.30 | -5.89 | 34.32 | -- | 3.77 | -- |
ELEVAI Labs Inc | 2.18m | -4.62m | 12.47m | 18.00 | -- | 4.60 | -- | 5.71 | -0.2665 | -0.2665 | 0.126 | 0.1435 | -- | -- | -- | 121,351.70 | -- | -- | -- | -- | 67.84 | -- | -211.42 | -- | 1.80 | -- | 0.00 | -- | 123.50 | -- | -138.94 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Great Point Capital LLCas of 05 Apr 2024 | 159.65k | 12.43% |
Renaissance Technologies LLCas of 31 Mar 2024 | 37.82k | 2.95% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 14.85k | 1.16% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 10.03k | 0.78% |
UBS Securities LLCas of 31 Mar 2024 | 1.17k | 0.09% |
Tower Research Capital LLCas of 31 Mar 2024 | 998.00 | 0.08% |
Morgan Stanley & Co. LLCas of 31 Mar 2024 | 659.00 | 0.05% |
Citigroup Global Markets, Inc. (Investment Management)as of 31 Mar 2024 | 373.00 | 0.03% |
Cornerstone Planning Group LLCas of 31 Mar 2024 | 37.00 | 0.00% |
Desjardins Securities, Inc.as of 31 Mar 2024 | 17.00 | 0.00% |